GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (LTS:0TDF) » Definitions » Float Percentage Of Total Shares Outstanding

Roche Holding AG (LTS:0TDF) Float Percentage Of Total Shares Outstanding : 0.00% (As of Dec. 13, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Roche Holding AG Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Roche Holding AG's float shares is 0.00 Mil. Roche Holding AG's total shares outstanding is 6,374.31 Mil. Roche Holding AG's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Roche Holding AG's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Roche Holding AG's Institutional Ownership is 0.95%.

Roche Holding AG Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Roche Holding AG's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/6,374.31
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roche Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (LTS:0TDF) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XSWX:NOVN XSWX:COPN LLY OCSE:NOVO B JNJ ABBV MRK LSE:AZN AMGN PFE XPAR:SAN BMY GILD LSE:GSK TSE:4519 TSE:4568 SHSE:600276 TSE:4578 BIIB XTER:BAYN
Traded in Other Exchanges
RHHVF:USA RHHBY:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0QQ6:UK 0QOK:UK RHO6:Germany ROG:Switzerland RO:Switzerland
Address
Grenzacherstrasse 124, Basel, CHE, 4070
Website
https://www.roche.com
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Roche Holding AG Headlines

No Headlines